Type 1 diabetes: Metabolic impairments as a predictor in people at risk?

被引：0
|
作者：
Simon, Annika
机构：
来源：
DIABETOLOGIE UND STOFFWECHSEL | 2023年 / 18卷 / 02期
关键词：
D O I：
10.1055/a-1945-1461
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Nachdem eine Therapie mit dem humanen monoklonalen Antikorper Teplizumab in einer Studie die Manifestation eines Typ-1-Diabetes bei Kindern mit hohem Risiko um knapp 3 Jahre verzogern konnte, ist die Suche nach den zugrunde liegenden Mechanismen einer Progression in vollem Gange. So wollten Sims et al. mogliche Unterschiedene zwischen Progressoren und Nicht-Progressoren identifizieren und haben eine retrospektive Beobachtungsstudie durchgefuhrt.
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [21] Effect of pramlintide on metabolic control and safety profile in people with type 1 diabetes
    Rosenstock, J
    Whitehouse, F
    Schoenfeld, S
    Dean, E
    Blonde, L
    Kolterman, O
    DIABETES, 1998, 47 : A88 - A88
  • [22] Metabolic effect of epinephrine infusion in people with type 1 diabetes and healthy individuals
    She, R.
    Suvitaival, T.
    Andersen, H. U.
    Hommel, E.
    Norgaard, K.
    Wojtaszewski, J.
    Legido-Quigley, C.
    Pedersen-Bjergaard, U.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S257 - S257
  • [23] Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals
    She, Rui
    Suvitaival, Tommi
    Andersen, Henrik U.
    Hommel, Eva
    Norgaard, Kirsten
    Wojtaszewski, Jorgen F. P.
    Legido-Quigley, Cristina
    Pedersen-Bjergaard, Ulrik
    DIABETOLOGIA, 2024, 67 (06) : 1095 - 1106
  • [24] Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals
    Rui She
    Tommi Suvitaival
    Henrik U. Andersen
    Eva Hommel
    Kirsten Nørgaard
    Jørgen F. P. Wojtaszewski
    Cristina Legido-Quigley
    Ulrik Pedersen-Bjergaard
    Diabetologia, 2024, 67 : 1095 - 1106
  • [25] Metabolic tests to determine risk for type 1 diabetes in clinical trials
    Greenbaum, Carla J.
    Buckingham, B.
    Chase, H. P.
    Krischer, J.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2011, 27 (06) : 584 - 589
  • [26] Obesity and risk factors for metabolic syndrome in young people with type 1 diabetes (vol 72, pg 291, 2012)
    Prieto, Mariana
    Krochik, Andre G.
    Chaler, Eduardo
    Maceiras, Mercedes
    Villalba, Anabel
    Valdez, Silvina
    Cerrone, Gloria
    Tellechea, Mariana
    Mazza, Carmen
    MEDICINA-BUENOS AIRES, 2012, 72 (05) : 438 - 438
  • [27] The cardiovascular risk in patients with type 1 diabetes mellitus and metabolic syndrome
    Timar, R. Z.
    Serban, V.
    Diaconu, L.
    Botea, V.
    Vlad, A.
    Sima, A.
    Rosu, M.
    DIABETOLOGIA, 2006, 49 : 228 - 229
  • [28] Erratum to: Cardiovascular Disease Risk in Young People with Type 1 Diabetes
    Janet K. Snell-Bergeon
    Kristen Nadeau
    Journal of Cardiovascular Translational Research, 2012, 5 (4) : 554 - 554
  • [29] Extreme ischaemic heart disease risk in people with type 1 diabetes
    Herrington, William G.
    Bragg, Fiona
    HEART, 2017, 103 (21) : 1656 - 1657
  • [30] Identifying people at risk of developing type 2 diabetes: A comparison of predictive analytics techniques and predictor variables
    Talaei-Khoei, Amir
    Wilson, James M.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2018, 119 : 22 - 38
12345